Alembic Pharmaceuticals informs about press release

27 Oct 2022 Evaluate

Alembic Pharmaceuticals has informed the exchange that the company has received US Food & Drug Administration (USFDA) Final Approval for Paclitaxel Injection USP, 30 mg/5 mL (6 mg/mL), 100 mg/16.7 mL (6 mg/mL), and 300 mg/50 mL (6 mg/mL) Multiple-Dose Vials. The company has enclosed a press release in this regard.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

762.40 -7.80 (-1.01%)
20-Jan-2026 09:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.00
Dr. Reddys Lab 1163.75
Cipla 1389.85
Zydus Lifesciences 880.50
Lupin 2166.85
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×